Gregory P. Rouen

Statistics

Publications

Citations

338

H-Index

Active since

1997

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Gregory P. Rouen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, pharmacology, and medicinal chemistry.

Publications per year

1997–2005

Publications

Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase

Jeffrey H. Toney, Gail G. Hammond, Paula M.D. Fitzgerald et al. · Journal of Biological Chemistry · 2001 · 200 citations · Full text

Life Sciences, Microbiology, Pharmacology +16

Dicationic 2-fluorenonylcarbapenems: Potent anti-MRS agents with improved solubility and pharmacokinetic properties

Mark L. Greenlee, Joanne B. Laub, Gregory P. Rouen et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 61 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacokinetics +17

Dolastatins. 26. Synthesis and Stereochemistry of Dolastatin 11<sup>1</sup><sup>a</sup>

Robert B. Bates, Kennard G. Brusoe, Jennifer Burns et al. · Journal of the American Chemical Society · 1997 · 43 citations

Natural Sciences, Medicinal Chemistry, Pharmacology +14

Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity

Cameron J. Smith, Amjad Ali, James M. Balkovec et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 34 citations · Full text

Medicine, Endocrinology, Pharmacology +11

1–4 of 4